title: [Serum levels of IAP, CEA and CA19-9 in patients with urological malignancies].
authors.forename: T
authors.initials: T
authors.lastname: Iizumi
authors.forename: H
authors.initials: H
authors.lastname: Amemiya
authors.forename: R
authors.initials: R
authors.lastname: Hata
authors.forename: S
authors.initials: S
authors.lastname: Kaneko
authors.forename: H
authors.initials: H
authors.lastname: Muramatsu
authors.forename: T
authors.initials: T
authors.lastname: Kariba
authors.forename: A
authors.initials: A
authors.lastname: Toyoshima
authors.forename: T
authors.initials: T
authors.lastname: Yazaki
authors.forename: M
authors.initials: M
authors.lastname: Waku
mesh_terms: D000368:Aged; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis*; D009367:Neoplasm Staging; D011379:Prognosis; D014571:Urologic Neoplasms / Q000175:diagnosis* / Q000473:pathology
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D009363:Neoplasm Proteins; C030193:immunosuppressive acidic protein